Evidence map›Paper›PMID 41723766›Full record

ArticleMolecular diversity2026

TaLiRAGen: target-aware ligand generation via retrieval-augmented large language models.

Xiaofei Nan, Xing You, Xuezhen Liu, Hongde Liu, Chengxiang Ji, Yongsheng Du, Jinshuai Song

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. PharmaGNN: a model for odor prediction based on graph neural networks.Journal of the science of food and agriculture · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaofei NanSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China. iexfnan@zzu.edu.cn.ORCID http://orcid.org/0000-0001-9145-1111
Xing YouSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0009-0004-9653-7845
Xuezhen LiuSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0009-0000-8991-6768
Hongde LiuSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0009-0003-3267-5002
Chengxiang JiSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0009-0001-6523-8584
Yongsheng DuSchool of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0009-0000-8377-2521
Jinshuai SongSchool of Chemistry, Zhengzhou University, Zhengzhou, 450001, China.ORCID http://orcid.org/0000-0002-1909-9253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generating ligands with high binding affinity for specific protein targets is a fundamental challenge in structure-based drug design. While generative models like VAEs and diffusion models show promise, they suffer from two key limitations: heavy dependence on target-specific training data and underutilization of vast biochemical knowledge. To overcome these issues, we propose TaLiRAGen, a no-training framework for target-aware ligand generation. Our method leverages general chemical knowledge embedded in Large Language Models (LLMs) through Retrieval-Augmented Generation (RAG), eliminating the need for target-specific model training. TaLiRAGen retrieves protein-ligand contexts from diverse repositories, integrates them through Chain-of-Thought (CoT)-augmented multi-turn prompting, and refines molecules via docking feedback. To enhance LLM’s ability in evaluating generated ligands, a unified evaluation metric is developed using evidence-theoretic normalization, jointly assessing binding affinity and drug-like properties. Critically, TaLiRAGen enables flexible, prompt-driven customization, successfully generating ligands that meet diverse structural requirements (e.g., LogP, ring count) for therapeutic targets. The codes and models are available in the supplement materials.

Indexed as

Drug DesignLarge Language ModelsProteinsSoftwareLigandsProtein BindingLigandsProteinsChain-of-thought reasoningConstrained ligand generationEvidence-theoretic normalizationRetrieval-augmented generationStructure-based drug design

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.